MolDX: Biomarker Testing for Risk Stratification in Metabolic Dysfunction-Associated Steatotic Liver Disease and Metabolic Dysfunction-Associated Steatohepatitis
J15
16 active Medicare policies list E66.3, and 5 commercial payer policies list it. See each policy's status for the code and its official source. Listing a code is not a coverage decision: read each policy’s source for the requirements that apply.
Free account. Policy pages stay open to everyone.
J15
J5
J8
J15 · Effective Aug 10, 2026
JE · Effective Aug 10, 2026
JF · Effective Aug 10, 2026
JJ · Effective Aug 10, 2026
5 policies from 3 payers
Summary of the payer’s published policy. Not a coverage determination — confirm with the payer before submitting.
| Policy | Effective | Status of E66.3 |
|---|---|---|
| Acupuncture and Dry Needling | Apr 5, 2023 | Covered |
| Nutritional Counseling | Aug 8, 2023 | Covered |
| Policy | Effective | Status of E66.3 |
|---|---|---|
| 25-hydroxyvitamin D Testing in Children and Adolescents | Not recorded | Covered |
| Thyroid Hormones and Insulin Testing in Pediatrics | Not recorded | Covered |
JM · Effective Aug 10, 2026
J5 · Effective Aug 10, 2026
J8 · Effective Aug 10, 2026
J9 · Effective Oct 1, 2015
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
National · Effective Oct 1, 2026
J9 · Effective Feb 26, 2026
| Policy | Effective | Status of E66.3 |
|---|---|---|
| Bariatric Surgery and Other Treatments for Clinically Severe Obesity | Oct 1, 2026 | Covered |